Literature DB >> 29086341

Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.

Emily C Williams1,2, Carol E Achtmeyer3,4,5, Jessica P Young3, Douglas Berger4,6, Geoffrey Curran7, Katharine A Bradley3,8,5,6, Julie Richards3,8, Michael B Siegel9, Evette J Ludman10, Gwen T Lapham3,5, Mark Forehand11, Alex H S Harris12.   

Abstract

BACKGROUND: Three medications are FDA-approved and recommended for treating alcohol use disorders (AUD) but they are not offered to most patients with AUD. Primary care (PC) may be an optimal setting in which to offer and prescribe AUD medications, but multiple barriers are likely.
OBJECTIVE: This qualitative study used social marketing theory, a behavior change approach that employs business marketing techniques including "segmenting the market," to describe (1) barriers and facilitators to prescribing AUD medications in PC, and (2) beliefs of PC providers after they were segmented into groups more and less willing to prescribe AUD medications.
DESIGN: Qualitative, interview-based study. PARTICIPANTS: Twenty-four providers from five VA PC clinics. APPROACH: Providers completed in-person semi-structured interviews, which were recorded, transcribed, and analyzed using social marketing theory and thematic analysis. Providers were divided into two groups based on consensus review. KEY
RESULTS: Barriers included lack of knowledge and experience, beliefs that medications cannot replace specialty addiction treatment, and alcohol-related stigma. Facilitators included training, support for prescribing, and behavioral staff to support follow-up. Providers more willing to prescribe viewed prescribing for AUD as part of their role as a PC provider, framed medications as a potentially effective "tool" or "foot in the door" for treating AUD, and believed that providing AUD medications in PC might catalyze change while reducing stigma and addressing other barriers to specialty treatment. Those less willing believed that medications could not effectively treat AUD, and that treating AUD was the role of specialty addiction treatment providers, not PC providers, and would require time and expertise they do not have.
CONCLUSIONS: We identified barriers to and facilitators of prescribing AUD medications in PC, which, if addressed and/or capitalized on, may increase provision of AUD medications. Providers more willing to prescribe may be the optimal target of a customized implementation intervention to promote changes in prescribing.

Entities:  

Keywords:  alcohol use disorders; barriers; facilitators; medication-assisted treatment; pharmacotherapy; social marketing

Mesh:

Year:  2017        PMID: 29086341      PMCID: PMC5834954          DOI: 10.1007/s11606-017-4202-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  49 in total

Review 1.  The effectiveness of social marketing interventions for health improvement: what's the evidence?

Authors:  Ross Gordon; Laura McDermott; Martine Stead; Kathryn Angus
Journal:  Public Health       Date:  2006-11-13       Impact factor: 2.427

2.  Estimating the effect of help-seeking on achieving recovery from alcohol dependence.

Authors:  Deborah A Dawson; Bridget F Grant; Frederick S Stinson; Patricia S Chou
Journal:  Addiction       Date:  2006-06       Impact factor: 6.526

3.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

Review 4.  Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Authors:  Elizabeth M Oliva; Natalya C Maisel; Adam J Gordon; Alex H S Harris
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

5.  A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence.

Authors:  Helen M Pettinati; Roger D Weiss; William Dundon; William R Miller; Dennis Donovan; Denise B Ernst; Bruce J Rounsaville
Journal:  J Stud Alcohol Suppl       Date:  2005-07

6.  Developing effective collaboration between primary care and mental health providers.

Authors:  Bradford L Felker; Edmund Chaney; Lisa V Rubenstein; Laura M Bonner; Elizabeth M Yano; Louise E Parker; Linda L M Worley; Scott E Sherman; Scott Ober
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

7.  Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.

Authors:  Emily C Williams; Jessica P Young; Carol E Achtmeyer; Christian S Hendershot
Journal:  J Subst Abuse Treat       Date:  2016-07-30

8.  Implementation of the patient-centered medical home in the Veterans Health Administration: associations with patient satisfaction, quality of care, staff burnout, and hospital and emergency department use.

Authors:  Karin M Nelson; Christian Helfrich; Haili Sun; Paul L Hebert; Chuan-Fen Liu; Emily Dolan; Leslie Taylor; Edwin Wong; Charles Maynard; Susan E Hernandez; William Sanders; Ian Randall; Idamay Curtis; Gordon Schectman; Richard Stark; Stephan D Fihn
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

9.  Physicians' opinions about medications to treat alcoholism.

Authors:  Tami L Mark; Henry R Kranzler; Xue Song; Peace Bransberger; Virginia H Poole; Scott Crosse
Journal:  Addiction       Date:  2003-05       Impact factor: 6.526

10.  Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation.

Authors:  Robert J Reid; Paul A Fishman; Onchee Yu; Tyler R Ross; James T Tufano; Michael P Soman; Eric B Larson
Journal:  Am J Manag Care       Date:  2009-09-01       Impact factor: 2.229

View more
  31 in total

1.  Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders.

Authors:  Paul J Joudrey; Benjamin J Oldfield; Kimberly A Yonkers; Patrick G O'Connor; Gretchen Berland; E Jennifer Edelman
Journal:  Drug Alcohol Depend       Date:  2020-06-02       Impact factor: 4.492

2.  Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.

Authors:  Elizabeth Bromley; Derjung M Tarn; Michael McCreary; Brian Hurley; Allison J Ober; Katherine E Watkins
Journal:  J Subst Abuse Treat       Date:  2020-04-20

3.  Association Between Gabapentin Receipt for Any Indication and Alcohol Use Disorders Identification Test-Consumption Scores Among Clinical Subpopulations With and Without Alcohol Use Disorder.

Authors:  Christopher T Rentsch; David A Fiellin; Kendall J Bryant; Amy C Justice; Janet P Tate
Journal:  Alcohol Clin Exp Res       Date:  2019-02-03       Impact factor: 3.455

4.  Increasing Prevalence of Alcohol Use Disorders: Meeting the Challenge in Primary Care : Commentary on Williams et al., Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.

Authors:  Barbara J Turner; Charles W Mathias
Journal:  J Gen Intern Med       Date:  2018-03       Impact factor: 5.128

5.  JGIM Embraces Your Work on Substance Use.

Authors:  Carol K Bates
Journal:  J Gen Intern Med       Date:  2018-03       Impact factor: 5.128

6.  Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps.

Authors:  Jessica J Wyse; Adam J Gordon; Steven K Dobscha; Benjamin J Morasco; Elizabeth Tiffany; Karen Drexler; Friedhelm Sandbrink; Travis I Lovejoy
Journal:  Subst Abus       Date:  2018       Impact factor: 3.716

7.  Documented brief intervention associated with reduced linkage to specialty addictions treatment in a national sample of VA patients with unhealthy alcohol use with and without alcohol use disorders.

Authors:  Madeline C Frost; Joseph E Glass; Katharine A Bradley; Emily C Williams
Journal:  Addiction       Date:  2019-12-11       Impact factor: 6.526

8.  Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.

Authors:  Madeline C Frost; Theresa E Matson; Judith I Tsui; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2018-10-30       Impact factor: 4.492

9.  Receipt of alcohol-related care among patients with HCV and unhealthy alcohol use.

Authors:  Mandy D Owens; George N Ioannou; Judith L Tsui; E Jennifer Edelman; Preston A Greene; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

10.  Differences in Receipt of Alcohol-Related Care Across Rurality Among VA Patients Living With HIV With Unhealthy Alcohol Use.

Authors:  Kara M Bensley; John Fortney; Gary Chan; Julia C Dombrowski; India Ornelas; Anna D Rubinsky; Gwen T Lapham; Joseph E Glass; Emily C Williams
Journal:  J Rural Health       Date:  2019-01-31       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.